Avid Bioservices, Inc. – NASDAQ:CDMOP

Avid Bioservices stock price today

$25.06
Financial Health
0
1
2
3
4
5
6
7
8
9

Avid Bioservices stock price yearly change

-17.84%
year

Avid Bioservices key metrics

Market Cap
N/A
Enterprise value
1.44B
P/E
-6265
EV/Sales
12.49
EV/EBITDA
68.79
Price/Sales
12.21
Price/Book
25.03
PEG ratio
-30.24
EPS
-2.03
Revenue
154.60M
EBITDA
6.76M
Income
-128.95M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
12.13%
Oper. margin
15.04%
Gross margin
32.6%
EBIT margin
15.04%
EBITDA margin
4.38%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Avid Bioservices stock price history

Avid Bioservices stock forecast

Avid Bioservices financial statements

Avid Bioservices, Inc. (NASDAQ:CDMOP): Profit margin
Jan 2023 38.01M 461K 1.21%
Apr 2023 39.79M -309K -0.78%
Jan 2024 33.81M -6.00M -17.76%
Apr 2024 42.97M -123.10M -286.45%
0%
Yield TTM
Avid Bioservices, Inc. (NASDAQ:CDMOP): Payout ratio
Payout ratio 0%
Avid Bioservices, Inc. (NASDAQ:CDMOP): Dividend Yield
2020 1.26%
2021 0.36%
2022
2023
2024
Avid Bioservices, Inc. (NASDAQ:CDMOP): Debt to assets
Jan 2023 450430000 265.03M 58.84%
Apr 2023 451054000 261.58M 57.99%
Jan 2024 455227000 275.05M 60.42%
Apr 2024 336557000 275.66M 81.91%
Avid Bioservices, Inc. (NASDAQ:CDMOP): Cash Flow
Jan 2023 -6.91M -11.32M 868K
Apr 2023 2.79M -24.87M 704K
Jan 2024 3.68M -4.48M 85K
Apr 2024 1.25M -5.69M 11.83M

Avid Bioservices alternative data

Avid Bioservices, Inc. (NASDAQ:CDMOP): Employee count
Aug 2023 222
Sep 2023 222
Oct 2023 222
Nov 2023 222
Dec 2023 222
Jan 2024 222
Feb 2024 222
Mar 2024 222
Apr 2024 222
May 2024 222
Jun 2024 222
Jul 2024 222

Avid Bioservices other data

Avid Bioservices, Inc. (NASDAQ:CDMOP): Insider trades (number of shares)
Period Buy Sel
Mar 2021 126000 100000
Jul 2021 0 25232
Aug 2021 0 18701
Oct 2021 0 3895
Nov 2021 0 5000
Dec 2021 0 18258
Transaction Date Insider Security Shares Price per share Total value Source
Sale
ZIEBELL MARK R officer: V. P., G.. Common Stock, $0.001 par value 6,829 $30.27 $206,687
Option
ZIEBELL MARK R officer: V. P., G.. Stock Option (right to buy) 6,429 $3.29 $21,151
Sale
ZIEBELL MARK R officer: V. P., G.. Common Stock, $0.001 par value 6,429 $24.57 $157,948
Option
ZIEBELL MARK R officer: V. P., G.. Common Stock, $0.001 par value 6,429 $3.29 $21,151
Option
CARLEONE JOSEPH director
Restricted Stock Units 2,379 N/A N/A
Option
CARLEONE JOSEPH director
Common Stock, $0.001 par value 2,379 N/A N/A
Option
HANCOCK RICHARD B director
Restricted Stock Units 2,379 N/A N/A
Option
HANCOCK RICHARD B director
Common Stock, $0.001 par balue 2,379 N/A N/A
Option
MACKEY CATHERINE J director
Restricted Stock Units 2,379 N/A N/A
Option
MACKEY CATHERINE J director
Common Stock, $0.001 par value 2,379 N/A N/A
Wednesday, 18 December 2024
globenewswire.com
Tuesday, 10 December 2024
globenewswire.com
Wednesday, 6 November 2024
globenewswire.com
Thursday, 12 September 2024
globenewswire.com
Monday, 9 September 2024
globenewswire.com
Tuesday, 3 September 2024
globenewswire.com
Tuesday, 2 July 2024
globenewswire.com
Monday, 1 July 2024
globenewswire.com
Thursday, 23 May 2024
globenewswire.com
Tuesday, 7 May 2024
globenewswire.com
Wednesday, 24 April 2024
globenewswire.com
Wednesday, 20 March 2024
globenewswire.com
Wednesday, 6 March 2024
globenewswire.com
globenewswire.com
globenewswire.com
Thursday, 7 December 2023
globenewswire.com
Thursday, 30 November 2023
GlobeNewsWire
Thursday, 31 August 2023
GlobeNewsWire
Wednesday, 14 June 2023
GlobeNewsWire
Monday, 6 March 2023
GlobeNewsWire
Tuesday, 29 November 2022
GlobeNewsWire
Wednesday, 7 September 2022
GlobeNewsWire
Tuesday, 30 August 2022
GlobeNewsWire
Wednesday, 22 June 2022
GlobeNewsWire
  • What's the price of Avid Bioservices stock today?

    One share of Avid Bioservices stock can currently be purchased for approximately $25.06.

  • When is Avid Bioservices's next earnings date?

    Unfortunately, Avid Bioservices's (CDMOP) next earnings date is currently unknown.

  • Does Avid Bioservices pay dividends?

    No, Avid Bioservices does not pay dividends.

  • What is Avid Bioservices's stock symbol?

    Avid Bioservices, Inc. is traded on the NASDAQ under the ticker symbol "CDMOP".

  • What is Avid Bioservices's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Avid Bioservices?

    Shares of Avid Bioservices can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Avid Bioservices have?

    As Jul 2024, Avid Bioservices employs 222 workers.

  • When Avid Bioservices went public?

    Avid Bioservices, Inc. is publicly traded company for more then 3 years since IPO on 31 Jan 2022.

  • What is Avid Bioservices's official website?

    The official website for Avid Bioservices is avidbio.com.

  • Where are Avid Bioservices's headquarters?

    Avid Bioservices is headquartered at 2642 Michelle Drive, Tustin, CA.

  • How can i contact Avid Bioservices?

    Avid Bioservices's mailing address is 2642 Michelle Drive, Tustin, CA and company can be reached via phone at +7 145086100.

Avid Bioservices company profile:

Avid Bioservices, Inc.

avidbio.com
Exchange:

NASDAQ

Full time employees:

222

Industry:

Biotechnology

Sector:

Healthcare

Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. It produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, purification, bulk packaging, release and stability testing, and regulatory submission and support. The company also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. It serves biotechnology and pharmaceutical companies. Avid Bioservices, Inc. has a process development and manufacturing agreement with Oragenics, Inc. to develop coronavirus vaccine. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was founded in 1981 and is headquartered in Tustin, California.

2642 Michelle Drive
Tustin, CA 92780

CIK: 0000704562
:
: